Off-label quetiapine linked to safety concerns

Commonly prescribed medication for insomnia symptoms affects next-day performance in people with OSA, controlled trial finds Low-dose quetiapine in people with obstructive sleep apnea (OSA) and insomnia reduced OSA severity and increased sleep efficiency—but there was evidence of next-day impairment, an Australian study has found. The double-blind, randomised, placebo-controlled, cross-over study included 15 people with